Article Information
History
- July 8, 2024.
Article Versions
- You are currently viewing Version 1 of this article (July 8, 2024 - 10:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chemtai Mungo, MD, MPH1,2,*,
- Katherine Sorgi1,
- Cirillus Ogollah, BSc, DipCM4,
- Brenda Misiko4,
- Cynthia Cheserem4,
- George Githongo4 and
- Jackton Omoto, MBChB, MMed3
- 1Department of Obstetrics and Gynecology, University of North Carolina Chapel Hill, 321 S Columbia St, Chapel Hill, North Carolina, 27599, USA
- 2Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 450 West Dr, Chapel Hill, North Carolina, 27599, USA
- 3Department of Obstetrics and Gynecology, Maseno University School of Medicine, P.O, Kisumu, Kenya
- 4Kenya Medical Research Institute, Busia Rd, Kisumu, Kenya
- ↵*Corresponding Author: Chemtai Mungo, MD, MPH, chemtai_mungo{at}med.unc.edu
Posted July 08, 2024.
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya
